218 related articles for article (PubMed ID: 27096954)
1. Optical and nuclear imaging of glioblastoma with phosphatidylserine-targeted nanovesicles.
Blanco VM; Chu Z; LaSance K; Gray BD; Pak KY; Rider T; Greis KD; Qi X
Oncotarget; 2016 May; 7(22):32866-75. PubMed ID: 27096954
[TBL] [Abstract][Full Text] [Related]
2. Detection of cancer cells using SapC-DOPS nanovesicles.
Davis HW; Hussain N; Qi X
Mol Cancer; 2016 May; 15(1):33. PubMed ID: 27160923
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidylserine-selective targeting and anticancer effects of SapC-DOPS nanovesicles on brain tumors.
Blanco VM; Chu Z; Vallabhapurapu SD; Sulaiman MK; Kendler A; Rixe O; Warnick RE; Franco RS; Qi X
Oncotarget; 2014 Aug; 5(16):7105-18. PubMed ID: 25051370
[TBL] [Abstract][Full Text] [Related]
4. In vivo optical imaging of brain tumors and arthritis using fluorescent SapC-DOPS nanovesicles.
Chu Z; LaSance K; Blanco V; Kwon CH; Kaur B; Frederick M; Thornton S; Lemen L; Qi X
J Vis Exp; 2014 May; (87):. PubMed ID: 24837630
[TBL] [Abstract][Full Text] [Related]
5. Systemic delivery of SapC-DOPS has antiangiogenic and antitumor effects against glioblastoma.
Wojton J; Chu Z; Mathsyaraja H; Meisen WH; Denton N; Kwon CH; Chow LM; Palascak M; Franco R; Bourdeau T; Thornton S; Ostrowski MC; Kaur B; Qi X
Mol Ther; 2013 Aug; 21(8):1517-25. PubMed ID: 23732993
[TBL] [Abstract][Full Text] [Related]
6. Development of PEGylated peptide probes conjugated with (18)F-labeled BODIPY for PET/optical imaging of MT1-MMP activity.
Kondo N; Temma T; Deguchi J; Sano K; Ono M; Saji H
J Control Release; 2015 Dec; 220(Pt A):476-483. PubMed ID: 26578437
[TBL] [Abstract][Full Text] [Related]
7. Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles.
Davis HW; Vallabhapurapu SD; Chu Z; Wyder MA; Greis KD; Fannin V; Sun Y; Desai PB; Pak KY; Gray BD; Qi X
Cells; 2020 Aug; 9(9):. PubMed ID: 32854321
[TBL] [Abstract][Full Text] [Related]
8. Radiolabeled novel mAb 4G1 for immunoSPECT imaging of EGFRvIII expression in preclinical glioblastoma xenografts.
Liu X; Dong C; Shi J; Ma T; Jin Z; Jia B; Liu Z; Shen L; Wang F
Oncotarget; 2017 Jan; 8(4):6364-6375. PubMed ID: 28031526
[TBL] [Abstract][Full Text] [Related]
9. Targeting and cytotoxicity of SapC-DOPS nanovesicles in pancreatic cancer.
Chu Z; Abu-Baker S; Palascak MB; Ahmad SA; Franco RS; Qi X
PLoS One; 2013; 8(10):e75507. PubMed ID: 24124494
[TBL] [Abstract][Full Text] [Related]
10. Imaging of brain tumors with paramagnetic vesicles targeted to phosphatidylserine.
Winter PM; Pearce J; Chu Z; McPherson CM; Takigiku R; Lee JH; Qi X
J Magn Reson Imaging; 2015 Apr; 41(4):1079-87. PubMed ID: 24797437
[TBL] [Abstract][Full Text] [Related]
11. SapC-DOPS nanovesicles induce Smac- and Bax-dependent apoptosis through mitochondrial activation in neuroblastomas.
Sulaiman MK; Chu Z; Blanco VM; Vallabhapurapu SD; Franco RS; Qi X
Mol Cancer; 2015 Apr; 14():78. PubMed ID: 25889084
[TBL] [Abstract][Full Text] [Related]
12. Saposin C coupled lipid nanovesicles specifically target arthritic mouse joints for optical imaging of disease severity.
Qi X; Flick MJ; Frederick M; Chu Z; Mason R; DeLay M; Thornton S
PLoS One; 2012; 7(3):e33966. PubMed ID: 22470501
[TBL] [Abstract][Full Text] [Related]
13. Integrin α
Shi X; Shen L
J Inorg Biochem; 2018 Sep; 186():257-263. PubMed ID: 29990749
[TBL] [Abstract][Full Text] [Related]
14. NIRF Optical/PET Dual-Modal Imaging of Hepatocellular Carcinoma Using Heptamethine Carbocyanine Dye.
Zhang C; Zhao Y; Zhao N; Tan D; Zhang H; Chen X; Zhang H; An J; Shi C; Li M
Contrast Media Mol Imaging; 2018; 2018():4979746. PubMed ID: 29706843
[TBL] [Abstract][Full Text] [Related]
15. Structurally symmetric near-infrared fluorophore IRDye78-protein complex enables multimodal cancer imaging.
Yang J; Zhao C; Lim J; Zhao L; Tourneau RL; Zhang Q; Dobson D; Joshi S; Pang J; Zhang X; Pal S; Andreou C; Zhang H; Kircher MF; Schmitthenner H
Theranostics; 2021; 11(6):2534-2549. PubMed ID: 33456558
[No Abstract] [Full Text] [Related]
16. Improved synthesis of no-carrier-added p-[124I]iodo-L-phenylalanine and p-[131I]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomas.
Israel I; Brandau W; Farmakis G; Samnick S
Appl Radiat Isot; 2008 Apr; 66(4):513-22. PubMed ID: 18024046
[TBL] [Abstract][Full Text] [Related]
17. SapC-DOPS nanovesicles as targeted therapy for lung cancer.
Zhao S; Chu Z; Blanco VM; Nie Y; Hou Y; Qi X
Mol Cancer Ther; 2015 Feb; 14(2):491-8. PubMed ID: 25670331
[TBL] [Abstract][Full Text] [Related]
18. A practical method for multimodal registration and assessment of whole-brain disease burden using PET, MRI, and optical imaging.
Scarpelli ML; Healey DR; Mehta S; Kodibagkar VD; Quarles CC
Sci Rep; 2020 Oct; 10(1):17324. PubMed ID: 33057180
[TBL] [Abstract][Full Text] [Related]
19. Dual-Modality Optical/PET Imaging of PARP1 in Glioblastoma.
Carlucci G; Carney B; Brand C; Kossatz S; Irwin CP; Carlin SD; Keliher EJ; Weber W; Reiner T
Mol Imaging Biol; 2015 Dec; 17(6):848-55. PubMed ID: 25895168
[TBL] [Abstract][Full Text] [Related]
20. Dynamic In Vivo SPECT Imaging of Neural Stem Cells Functionalized with Radiolabeled Nanoparticles for Tracking of Glioblastoma.
Cheng SH; Yu D; Tsai HM; Morshed RA; Kanojia D; Lo LW; Leoni L; Govind Y; Zhang L; Aboody KS; Lesniak MS; Chen CT; Balyasnikova IV
J Nucl Med; 2016 Feb; 57(2):279-84. PubMed ID: 26564318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
